SCHEMBL131334

SCHEMBL131334

C#CC(O)C1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7453432 1.00
SCHEMBL611508 0.88
SCHEMBL5548835 0.88
SCHEMBL9793964 0.88
SCHEMBL9793827 0.86 TP53 (0.41)
SCHEMBL9793843 0.86 TP53 (0.41)
SCHEMBL13674295 0.86 TP53 (0.41)
SCHEMBL612202 0.86 TP53 (0.41)
SCHEMBL9063598 0.86 TP53 (0.41)
SCHEMBL17889770 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1129567-C Process for preparation of cyclopropylacetylene derivatives KURARAY CO (JP) 2003-12-03 CN claimed
CN-1232815-A Process for preparation of cyclopropylacetylene derivatives KURARAY CO (JP) 1999-10-27 CN claimed
US-20260042759-A1 INHIBITOR CONTAINING BICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF SHANGHAI HANSOH BIOMEDICAL CO LTD (CN) 2026-02-12 US disclosed
US-12466823-B2 Inhibitor containing bicyclic derivative, preparation method therefor and use thereof SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) 2025-11-11 US disclosed
EP-3971187-B1 INHIBITOR CONTAINING BICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF SHANGHAI HANSOH BIOMEDICAL CO LTD (CN) 2025-05-07 EP disclosed
CN-117800904-A ROR gamma inhibitors containing sulfonyl structures 正大天晴药业集团股份有限公司 2024-04-02 CN disclosed
US-20230406865-A1 CRYSTAL FORM OF FREE BASE OF INHIBITOR CONTAINING BICYCLIC RING DERIVATIVE AND PREPARATION METHOD AND APPLICATION OF CRYSTAL FORM JIANGSU HANSOH PHARMACEUTICAL GROUP CO., LTD. (CN) 2023-12-21 US disclosed
CN-113166061-B ROR gamma inhibitors containing sulfonyl structures 正大天晴药业集团股份有限公司 2023-11-21 CN disclosed
EP-4245757-A1 CRYSTAL FORM OF FREE BASE OF INHIBITOR CONTAINING BICYCLIC RING DERIVATIVE AND PREPARATION METHOD AND APPLICATION OF CRYSTAL FORM Shanghai Hansoh Biomedical Co., Ltd. (CN) 2023-09-20 EP disclosed
CN-116528859-A Crystal form containing free alkali of di-fused ring derivative inhibitor and preparation method and application thereof 上海翰森生物医药科技有限公司 2023-08-01 CN disclosed
CN-116444515-A Di-ring derivative-containing inhibitor, preparation method and application thereof 上海翰森生物医药科技有限公司 2023-07-18 CN disclosed
EP-0866791-B1 DIAMINOPYRIMIDINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS ANTIBACTERIAL ARPIDA AG (CH) 2002-01-30 EP disclosed
EP-1149834-A1 Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial F. HOFFMANN-LA ROCHE AG (CH) 2001-10-31 EP disclosed
US-6143743-A TREATMENT OF NERVOUS SYSTEM DISORDERS DUPONT PHARMACEUTICALS COMPANY (US) 2000-11-07 US disclosed
EP-0994877-A1 IMIDAZOPYRIMIDINES AND IMIDAZOPYRIDINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS Du Pont Pharmaceuticals Company (US) 2000-04-26 EP disclosed
CN-1232815-A Process for preparation of cyclopropylacetylene derivatives KURARAY CO (JP) 1999-10-27 CN disclosed
WO-1999001454-A1 IMIDAZOPYRIMIDINES AND IMIDAZOPYRIDINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS DU PONT PHARMACEUTICALS COMPANY (US) 1999-01-14 WO disclosed
EP-0866791-A1 DIAMINOPYRIMIDINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS ANTIBACTERIAL F. HOFFMANN-LA ROCHE AG (CH) 1998-09-30 EP disclosed
US-5773446-A BACTERICIDES; CONTROLLING INFECTIONS HOFFMANN-LA ROCHE INC. (US) 1998-06-30 US disclosed
WO-1997020839-A1 DIAMINOPYRIMIDINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE AS ANTIBACTERIAL F. HOFFMANN-LA ROCHE AG (CH) 1997-06-12 WO disclosed